Avelumab in G3 NEC

NCT03278405 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Neuroendocrine Carcinoma

Interventions

DRUG: Avelumab

Sponsor

Sunnybrook Health Sciences Centre

Collaborators

[object Object]